Laurus Labs Ltd.

LAURUSLABS Share PricePharmaceuticals & Drugs

1,012.3

-7 (-0.7%)

As on December 12, 2025

Exchange Scrips: BSE540222NSELAURUSLABSISININE947Q01028

Market Cap54,650 Cr

P/E Ratio 152.34

Dividend Yield 0.06 %

Performance

Market performance

Open1,016.1
High1,027.5
Volumes12,44,218
Prev1,012.3
Low1,006.1
As on2025-12-12

Historical performance

1 Year High1,040.2
3 Year High1,040.2
5 Year High1,040.2
1 Year Low501.15
3 Year Low278.85
5 Year Low278.85

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
54,650
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
152.34
Dividend Yield
Dividend Yield
0.06 %

Investment Returns

1 Year
79.5%
3 Years
150.4%
5 Years
207.7%
10 Years
N/A

Technicals

IndicatorsValueSignal
5-DMA1,015.1Bearish
10-DMA1,018.12Bearish
20-DMA1,007.05Bullish
50-DMA959.02Bullish
100-DMA914.55Bullish
200-DMA774.21Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters1616161615
Foreign Investors---------------
Domestic Investors1616161615
Public Investors283662280207292889292198309048
Government111------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 152.34.
  • 3Y Stock Price CAGR of the stock is 36.6.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹11304 Million.
  • The company generated revenue of ₹55540 Million in the previous financial year.

Laurus Labs Ltd.

1012.3-7   (-0.7%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1764972.5
No. of Shares: 1744 (Approx)
Performance:76.5%
P/L: ₹764972.5

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month